clopidogrel and sirolimus

clopidogrel has been researched along with sirolimus in 125 studies

Research

Studies (125)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	63 (50.40)	29.6817
2010's	61 (48.80)	24.3611
2020's	1 (0.80)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Marks, AR; Marx, SO	1
Albiero, R; Colombo, A; Corvaja, N; Di Mario, C; Falotico, R; Stankovic, G; Takagi, T; Toutouzas, K	1
Colombo, A; Desmedt, B; Di Mario, C; Holmes, DR; Leon, MB; Louvard, Y; Ludwig, J; Morice, MC; Moses, JW; Spanos, V	1
Bachinsky, W; Bass, T; DeMaio, S; Fry, E; Holmes, DR; Kuntz, RE; Leon, MB; Moses, JW; Popma, JJ; Sawhney, N; Teirstein, PS	1
Bakhai, A; Berezin, RH; Carrozza, JP; Cohen, DJ; Githiora, L; Kuntz, RE; Lavelle, T; Leon, MB; Moses, JW; Shi, C; Zidar, JP	1
Weintraub, WS	1
Cox, N; Douglas, J; Fitzpatrick, M; Holmes, DR; Kuntz, RE; Lambert, C; Leon, MB; Mooney, M; Moses, JW; Popma, JJ; Yakubov, S	1
Karvouni, E; Katritsis, DG; Korovesis, S	1
Benito, B; Betriu, A; Masotti, M	1
Claussen, CD; Dinkelborg, LM; Duda, SH; Laule, M; Muschick, P; Reddig, F; Tepe, G; Tielemans, H; Wehrmann, M	1
Bui, A; Chu, WW; Clavijo, LC; Fournadjieva, J; Gevorkian, N; Kent, KM; Kim, SW; Kuchulakanti, PK; Ohlmann, P; Pichard, AD; Rha, SW; Satler, LF; Smith, K; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Berge, C; Deme, M; Gershlick, AH; Guagliumi, G; Guyon, P; Lotan, C; Schofer, J; Seth, A; Sousa, JE; Stoll, HP; Urban, P; Wijns, W	1
Bach, RG; Cohen, DJ; Decker, C; Jones, PG; Kettelkamp, R; Khanal, S; Krumholz, HM; Messenger, JC; Peterson, ED; Rumsfeld, JS; Spertus, JA; Vance, C	1
Dehmer, GJ; McAllister, RK; Meyer, TA	1
Ling, F; Wang, N; Xu, J; Yang, J; Ye, X; Zhang, X; Zhou, L	1
Aslani, A; Sharifkazemi, MB; Zamirian, M	1
Anstrom, KJ; Califf, RM; Eisenstein, EL; Harrington, RA; Kandzari, DE; Kong, DF; Kramer, JM; Mark, DB; Matchar, DB; Peterson, ED; Schulman, KA; Shaw, LK; Tuttle, RH	1
Gershlick, AH; Richardson, G	1
Bader, F; Brunner-La Rocca, HP; Buser, PT; Hunziker, P; Jeger, R; Kaiser, C; Mueller, C; Osswald, S; Pfisterer, M; Rickenbacher, P	1
Kereiakes, DJ	1
Grinius, V; Navickas, R; Unikas, R	1
Daemen, J; de Jaegere, PP; García-García, HM; Kukreja, N; Serruys, PW; Sianos, G; Tanimoto, S; van de Sande, M; van Domburg, RT	1
Holmes, DR; Kuntz, RE; Leon, MB; Mishkel, G; Moses, JW; Popma, JJ; Raizner, AE; Satler, LF; Teirstein, PS; Wang, P; Weisz, G; Wilensky, RL	1
Finn, AV; Gold, HK; John, MC; Joner, M; Kolodgie, F; Nakazawa, G; Newell, J; Virmani, R	1
Khurana, A; Vinayek, N	1
Alfonso, F	1
Falcone, EL; Tangri, N	1
LeLorier, J; Matteau, A	1
Bennett, CL; Benzuly, KH; Beohar, N; Davidson, CJ; Flaherty, JD; Goodreau, L; Kip, KE; Meyers, SN; Ricciardi, MJ; Vlachos, HA; Williams, DO	1
Aubry, P; Benamer, H; Ducrocq, G; Feldman, LJ; Himbert, D; Juliard, JM; Majdoub, MA; Sauguet, A; Steg, PG; Tchetche, D	1
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Escaned, J; Fernández, C; Fernández-Avilés, F; Gómez-Hospital, JA; Hernández-Antolín, R; Jiménez-Quevedo, P; Macaya, C; Moreno, R; Sabaté, M; SanMartín, M	1
Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E	1
Belli, G; Presbitero, P; Rossi, M; Zavalloni, D	1
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Gori, AM; Marcucci, R; Migliorini, A; Moschi, G; Paniccia, R; Santini, A	1
Amorn, AM; Cercek, B; Dohad, S; Forrester, JS; Kapoor, N; Kar, S; Kupferwasser, LI; Lee, MS; Makkar, RR; Mirocha, J; Shah, PK	1
Spinler, SA; Wilensky, RL	1
Bavry, AA; Bhatt, DL	1
Joyal, D; Rudski, L	1
Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC	1
Batyraliev, TA; Pershukov, IV	1
Atsma, DE; Bootsma, M; Dijkstra, J; Jukema, JW; Liem, SS; Oemrawsingh, PV; Putter, H; Schalij, MJ; Suraphakdee, N; van der Hoeven, BL; van der Wall, EE; Zeppenfeld, K	1
Biondi-Zoccai, GG; Bollati, M; Gambino, A; Lombardi, P; Sheiban, I	1
Eshtehardi, P; Eslami, M; Moayed, DA	1
Asakura, Y; Ehara, M; Katoh, O; Kimura, M; Kinoshita, Y; Matsubara, T; Nasu, K; Suzuki, T; Tanaka, N; Terashima, M; Tsuchikane, E	1
Alfonso, F; Angel, J; Bañuelos, C; Bethencourt, A; Cequier, A; Escaned, J; Hernández, R; Iñiguez, A; Jiménez-Quevedo, P; López-Mínguez, JR; Macaya, C; Martí, V; Morís, C; Pérez-Vizcayno, MJ; Sabaté, M; Suárez, A	1
Cao, Z; Cheng, WJ; Ge, HL; Guo, YH; Jia, de A; Liu, YY; Nie, B; Shi, DM; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhao, YX; Zhou, YJ	1
Cho, EJ; Her, SH; Jang, SW; Kim, DB; Kim, JH; Kwon, BJ; Park, CS; Park, HJ; Park, MW; Rho, TH; Shin, D	1
Baboushkin, T; Eisenberg, MJ; Filion, KB; Rinfret, S; Roy, AM	1
Dean, J; Wanjun, C; Yingxin, Z; Yonghe, G; Yujie, Z; Yuyang, L; Zheng, C	1
Ahn, CM; Hong, SJ; Kim, KA; Kim, YH; Lim, DS; Park, JS; Park, JY; Park, SM; Shim, WJ	1
Hartenthaler, B; Hofmann, R; Hönig, S; Kammler, J; Kerschner, K; Kypta, A; Lambert, T; Leisch, F; Steinwender, C	1
Bruskina, O; Byrne, RA; Dirschinger, J; Iijima, R; Kastrati, A; Laugwitz, KL; Massberg, S; Mehilli, J; Pache, J; Schömig, A; Schulz, S; Seyfarth, M	1
Barker, CM; Kandzari, DE; Nayak, KR; Price, MJ; Teirstein, PS	1
Angiolillo, DJ; Brugaletta, S; Campos, B; Cola, C; Martín Yuste, V; Sabaté, M	1
Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Mattos, LA; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF	1
Peters-Krabbendam, I; Serruys, PW; Sorop, O; van Beusekom, HM; van der Giessen, WJ	1
Chen, X; Gao, R; Han, Y; Jiang, T; Jing, Q; Li, H; Li, Y; Li, Z; Liu, H; Liu, Y; Qiu, J; Shang, X; Xu, B; Yang, L; Zhang, H	1
Margolis, JR	1
Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Maldonado, G; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF	1
Ako, J; Fitzgerald, PJ; Hirata, K; Honda, Y; Kato, H; Koo, BK; Miyoshi, N; Ogasawara, D; Otake, H; Sawada, T; Shinke, T; Shite, J; Tanino, Y	1
Akishita, M; Ako, J; Eto, M; Iijima, K; Ogawa, S; Ota, H; Ouchi, Y	1
Doganov, A; Formuszewicz, R; Gil, RJ; Rusicka-Piekarz, T; Vassilev, D	1
Ding, FH; DU, R; Hu, J; Shen, J; Shen, WF; Zhang, Q; Zhang, RY; Zhang, X; Zhao, LP	1
Cheong, SS; Cho, YH; Hong, MK; Hong, TJ; Jeong, MH; Kim, JJ; Kim, KS; Kim, YH; Lee, CW; Lee, JH; Lee, NH; Lee, SG; Lee, SH; Lim, DS; Park, DW; Park, SJ; Park, SW; Seong, IW; Seung, KB; Yang, JY; Yoon, J; Yun, SC	1
Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Fineschi, M; Gori, T; Grotti, S; Liistro, F; Pierli, C	1
Balbi, M; Barsotti, A; Bezante, GP; Brunelli, C; Fedele, M	1
Abele-Ohl, S; Eckl, S; Ensminger, SM; Heim, C; Hoffmann, J; Ramsperger-Gleixner, M; Weyand, M	1
Shen, WF	1
Al-Dehneh, A; Alkhouri, Y; Bikkina, M; Hamdan, A; Virk, H	1
Cho, BR; Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Han, KR; Hur, SH; Lee, S; Lee, SH; Lee, SY; Lim, DS; Park, HS; Park, JS; Rha, SW; Song, YB; Yoon, J	1
Haraguchi, Y; Hariki, H; Hirata, K; Honjo, T; Inoue, T; Ishida, T; Kawamori, H; Kozuki, A; Nishio, R; Sawada, T; Shinke, T; Shinohara, M; Shite, J; Toh, R	1
Caixeta, A; Gordon, P; Hermiller, JB; Jonnavithula, L; Lansky, AJ; Miquel-Hebert, K; Onuma, Y; Ruygrok, P; Serruys, PW; Sood, P; Stone, GW; Su, X; Sudhir, K; Veldhof, S; Yaqub, M	1
Arima, M; Matsuda, A; Nitta, M; Shimizu, M; Yoshida, K	1
Fearon, WF; Hunt, SA; Ikeno, F; Lee, DP; Ng, MK; Tremmel, JA; Yeung, AC	1
Cook, S; Garachemani, A; Jüni, P; Khattab, AA; Limacher, A; Löffel, L; Meier, B; Moschovitis, A; Pilgrim, T; Räber, L; Seiler, C; Stauffer, JC; Togni, M; Vogel, R; Wenaweser, P; Windecker, S	1
Columbo, J; Cui, J; Davis, M; Giugliano, GR; Lotfi, A; Mulvey, S; Schweiger, M; Wartak, S	1
Barone-Rochette, G; Danchin, N; Foote, A; Machecourt, J; Motreff, P; Quesada, JL; Vanzetto, G	1
Blackman, DJ; Blaxill, JM; Chitkara, K; Dorsch, MF; Greenwood, JP; McLenachan, JM; Shelton, RJ; Singh, R; Somers, K; Wheatcroft, SB	1
Abizaid, A; Chamié, D; Collet, CA; Costa, JR; Costa, R; Feres, F; Obregon, J; Siquera, D; Sousa, A; Sousa, JE; Staico, R	1
Borghesi, M; Campo, G; Cangiano, E; Castriota, F; Cavazza, C; Colombo, F; Ferrari, R; Frangione, A; Fucà, G; Kubbajeh, M; Marchesini, J; Minarelli, M; Monti, M; Parrinello, G; Percoco, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P	1
Renzulli, A; Rossi, M; Serraino, GF; Spadafora, A	1
Devlin, G; Hyde, L; Liang, M; Liew, TV; Puri, A	1
Ferraro, G; Gaita, F; Marcolongo, M; Moretti, C; Sheiban, I; Truffa, A	1
Chen, X; Han, Y; Jiang, T; Jing, Q; Li, Y; Liu, H; Ma, Y; Wang, G; Wang, S; Wang, X; Yan, G; Yang, L; Zhang, L; Zhu, G	1
Witzenbichler, B	1
Gao, RL; Han, YL; Jiang, TM; Jing, QM; Li, SM; Li, WM; Li, Y; Liu, HL; Qu, P; Xu, B; Yang, LX; Zhang, L; Zhang, QY	1
Abizaid, A; Bhatt, DL; Botelho, RV; Castello, H; Costa, RA; de Paula, JE; Devito, FS; Feres, F; Gusmão, MO; King, SB; Leon, MB; Mangione, JA; Marin-Neto, JA; Nicolela, E; Perin, MA; Salvadori, D	1
Abbott, JD; Faxon, D; Holper, E; Kelsey, S; Khandhar, S; Kip, KE; Kutcher, M; Lee, JS; Marroquin, OC; Mulukutla, SR; Selzer, F; Smith, C; Toma, C; Vlachos, HA; Williams, DO	1
Borghesi, M; Ferrari, R; Parrinello, G; Tebaldi, M; Valgimigli, M; Vranckx, P	1
Chen, F; Gao, Y; He, J; Luo, Y; Lv, S; Ren, X; Wu, C; Yu, X; Zhang, X; Zhang, Y	1
Chen, F; Chen, SL; Cheng, JP; Kan, J; Lin, L; Liu, LY; Liu, Y; Xu, HM; Zhao, YY	1
Eisenberg, MJ; Filion, KB; Grandi, SM; Huang, KN	1
Eckl, S; Ensminger, SM; Koch, N; Preidl, RH; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M	1
Abbate, R; Antoniucci, D; Carrabba, N; Gensini, GF; Marcucci, R; Migliorini, A; Parodi, G; Valenti, R	1
Abizaid, A; Abizaid, AS; Bhatt, DL; Botelho, RV; Castello, HJ; Costa, JR; Costa, RA; de Castro, JP; de Paula, JE; Devito, FS; Feres, F; Gusmão, M; King, SB; Labrunie, A; Leon, MB; Liu, M; Mangione, JA; Marin-Neto, JA; Meireles, GX; Negoita, M; Nicolela, EL; Perin, MA; Salvadori, D; Staico, R	1
Borghesi, M; Campo, G; Cangiano, E; Cavazza, C; Marchesini, J; Minarelli, M; Parrinello, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P	1
Ahn, SG; Choi, H; Hong, MK; Hong, YJ; Jang, Y; Kwon, HM; Lee, JW; Lee, SH; Yoon, J; Youn, YJ; Yu, CW	1
Belardi, JA; Brar, S; Kirtane, AJ; Liu, M; Rothman, M; Silber, S; Windecker, S	1
Al Kurdi, M; Boersma, E; Camenzind, E; Mauri, L; Ordoubadi, FF; Rademaker-Havinga, T; Steg, PG; Suttorp, MJ; Wijns, W	1
Eckl, S; Ensminger, SM; Goldmann, K; Heim, C; Koch, N; Preidl, R; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M	1
Chen, F; Loh, JP; Omar, A; Pendyala, LK; Pichard, AD; Satler, LF; Torguson, R; Waksman, R	1
Alfonso Manterola, F; Doncel Vecino, LJ; Fernández Díaz, JA; Fernández Portales, J; González Fernández, R; López Mínguez, JR; Martínez Cáceres, G; Martínez Romero, P; Merchán Herrera, A; Nogales Asensio, JM; Romany, S; Sandoval, J	1
Alber, H; Bonetti, PO; Eberli, F; Erne, P; Galatius, S; Jeger, RV; Kaiser, CA; Pedrazzini, G; Pfisterer, ME; Rickli, H; Sørensen, R; von Felten, S	1
Armengaud, J; Barragan, P; Benamer, H; Berland, J; Blanchard, D; Boschat, J; Bressolette, E; Carrie, D; Cassat, C; Castellant, P; Cazaux, P; Champagnac, D; Darremont, O; Dauphin, R; Delarche, N; Druelles, P; Dupouy, P; Endresen, K; Furber, A; Gilard, M; Gommeaux, A; Hovasse, T; Jouve, B; Kermarrec, A; Kiss, RG; Le Breton, H; Levy, G; Lyuycx-Bore, A; Maillard, L; Majwal, T; Morice, MC; Noor, HA; Noryani, AAL; Ohlmann, P; Ormezzano, O; Paganelli, F; Sainsous, J; Schneeberger, M; Ungi, I; Wojcik, J	1
Hirata, K; Iwasaki, M; Kinutani, H; Konishi, A; Masaru, K; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Sawada, T; Shinke, T; Shite, J; Takahashi, H; Takaya, T; Taniguchi, Y; Terashita, D	1
Choi, JH; Choi, RK; Choi, SH; Choi, YJ; Gwon, HC; Hahn, JY; Jang, HJ; Kim, JS; Kim, TH; Lee, HJ; Lee, SH; Park, JS; Park, TK; Roh, YM; Shim, WH; Song, YB; Yang, JH; Yu, CW	1
Cutlip, DE; Dauerman, HL; Kereiakes, DJ; Mauri, L; Stoler, R	1
Airoldi, F; Briguori, C; Campo, G; Colangelo, S; de Cesare, N; Dellavalle, A; Ferlini, M; Gabriel, HM; Garbo, R; Liistro, F; McFadden, E; Meliga, E; Menozzi, A; Patialiakas, A; Roffi, M; Tebaldi, M; Testa, L; Thury, A; Tondi, S; Ungi, I; Valgimigli, M; Vranckx, P	1
Kandzari, DE	1
Guo, XF; Han, YL; Li, B; Liu, Q; Lu, SZ; Pang, S; Su, X; Xu, B; Yang, YJ; Zhang, YJ; Zhao, YL	1
Akasaka, T; Hanawa, K; Hao, K; Hasebe, Y; Hirano, M; Ito, K; Matsumoto, Y; Miyata, S; Nishimiya, K; Ogata, T; Oyama, K; Shimokawa, H; Shindo, T; Takahashi, J; Tanaka, A; Taruya, A; Tsuburaya, R; Uzuka, H	1
Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Hur, SH; Jeong, JO; Kim, DI; Kim, HS; Park, HS; Ryu, DR; Song, PS; Song, YB	1
Dohi, K; Fujimoto, N; Fukuoka, S; Ito, M; Izumi, D; Miyahara, M; Sakai, M	1
Chang, K; Choi, YS; Chung, WB; Chung, WS; Kim, HY; Kim, JY; Kwon, A; Lee, MY; Park, CS; Seung, KB	1
Cao, X; Dangas, GD; Guan, C; Han, Y; Jing, Q; Li, J; Li, X; Pang, W; Wang, H; Wang, Z; Xu, B; Xu, K; Yang, Y; Yu, P; Zang, H; Zhang, J; Zhao, X; Zheng, Q	1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, HS; Kim, JS; Ko, YG; Lee, SY; Palmerini, T; Shin, DH; Stone, GW; Valgimigli, M	1
Cho, DK; Choi, JH; Choi, SH; Doh, JH; Gwon, HC; Hahn, JY; Kim, SH; Lee, JB; Lee, JM; Lee, SH; Oh, JH; Park, TK; Song, YB; Yang, JH	1
Abizaid, A; Costa, JR; Costa, R; Feres, F; Mangione, JA; Piva E Mattos, LA; Siqueira, D; Sousa, A; Staico, R; Zuliani Mauro, MF	1
Cho, DK; Choi, S; Hong, BK; Hong, MK; Jang, Y; Jeon, DW; Kang, TS; Kang, WC; Kim, BK; Kim, BO; Kim, JS; Kim, S; Kim, YH; Kwon, HM; Lee, BK; Lee, OH; Min, PK; Shin, DH; Woo, SI; Yoon, YW	1
Açıl, T; Doğan, A; Kahraman, S; Kurtoğlu, N; Özdemir, E; Saltan, Y	1
Fujimoto, W; Kawai, H; Miyata, T; Oishi, S; Onishi, T; Osue, T; Sawada, T; Shimane, A; Takahashi, Y; Takaya, T; Taniguchi, Y; Toba, T; Yasaka, Y	1
Briguori, C; Condorelli, G; D'Alessio, F; D'Amore, C; De Caterina, R; Del Vecchio, L; Donahue, M; Quintavalle, C; Signoriello, G	1
Bae, JW; Cho, BR; Cho, DK; Cho, JH; Choi, JH; Choi, JW; Choi, SH; Choi, WG; Chun, WJ; Gwon, HC; Hahn, JY; Im, ES; Jang, WJ; Jeong, JO; Koh, YY; Lee, JM; Lee, JY; Lee, SH; Lee, SU; Lee, SY; Lee, WS; Oh, JH; Oh, SK; Park, TK; Park, YH; Rha, SW; Song, YB; Yang, JH; Yoon, HJ; Yun, KH	1

Reviews

10 review(s) available for clopidogrel and sirolimus

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Sirolimus-eluting stents: a review of experimental and clinical findings. Zeitschrift fur Kardiologie, 2002, Volume: 91 Suppl 3 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Animals; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Disease Models, Animal; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intramuscular; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Rats; Sirolimus; Stents; Swine; Thrombosis; Ticlopidine; Time Factors; Ultrasonography, Interventional	2002
[Advances in adjunctive pharmacological therapy for percutaneous coronary interventions]. Revista espanola de cardiologia, 2005, Volume: 58, Issue:6 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Cardiac Catheterization; Clopidogrel; Coronary Restenosis; Factor X; Fibrinolytic Agents; Follow-Up Studies; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Immunosuppressive Agents; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Thrombolytic Therapy; Thrombosis; Ticlopidine; Time Factors	2005
[Stents in interventional cardiology]. Medicina (Kaunas, Lithuania), 2007, Volume: 43, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug Delivery Systems; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Platelet Aggregation Inhibitors; Prednisolone; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2007
[Drug-eluting stent thrombosis and its pharmacological prevention]. Kardiologiia, 2007, Volume: 47, Issue:7 Topics: Aspirin; Clopidogrel; Death, Sudden, Cardiac; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Incidence; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Terminology as Topic; Thrombosis; Ticlopidine; Turkey	2007
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization. Vascular health and risk management, 2009, Volume: 5, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Humans; Medication Adherence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Ticlopidine; Treatment Outcome	2009
Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review. Texas Heart Institute journal, 2010, Volume: 37, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Drug Administration Schedule; Drug-Eluting Stents; Electrocardiography; Humans; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2010
What do you do with the antiplatelet agents in patients with drug eluting stents who then receive a mechanical valve? Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:1 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Aspirin; Benchmarking; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Evidence-Based Medicine; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome	2012
Late and very late stent thrombosis in patients with second-generation drug-eluting stents. The Canadian journal of cardiology, 2013, Volume: 29, Issue:11 Topics: Aspirin; Cardiotonic Agents; Clopidogrel; Drug-Eluting Stents; Everolimus; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Thrombosis; Ticlopidine; Time Factors	2013
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. European heart journal, 2014, Aug-01, Volume: 35, Issue:29 Topics: Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment	2014

Trials

36 trial(s) available for clopidogrel and sirolimus

Article	Year
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 2004, Mar-16, Volume: 109, Issue:10 Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Death, Sudden; Diabetes Mellitus; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Safety; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome	2004
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation, 2004, Jul-27, Volume: 110, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Double-Blind Method; Drug Implants; Female; Humans; Life Tables; Male; Middle Aged; Myocardial Infarction; Premedication; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome; Ultrasonography	2004
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation, 2004, Aug-03, Volume: 110, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiac Catheterization; Clopidogrel; Coronary Restenosis; Cost-Benefit Analysis; Diabetes Mellitus; Double-Blind Method; Drug Costs; Equipment Design; Female; Follow-Up Studies; Health Care Costs; Health Resources; Hospital Costs; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Sirolimus; Stents; Ticlopidine; Treatment Outcome; United States	2004
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation, 2004, Dec-21, Volume: 110, Issue:25 Topics: Aged; Aspirin; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Double-Blind Method; Drug Implants; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Incidence; Male; Middle Aged; Randomized Controlled Trials as Topic; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2004
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. Journal of the American College of Cardiology, 2006, Dec-19, Volume: 48, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2006
Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). The American journal of cardiology, 2007, Apr-15, Volume: 99, Issue:8 Topics: Angioplasty, Balloon, Coronary; Cause of Death; Clopidogrel; Cohort Studies; Coronary Restenosis; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Registries; Retrospective Studies; Sirolimus; Stents; Survival Rate; Ticlopidine; Treatment Outcome	2007
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). The American journal of cardiology, 2007, Apr-15, Volume: 99, Issue:8 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retreatment; Retrospective Studies; Safety; Sirolimus; Stents; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome	2007
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. European heart journal, 2007, Volume: 28, Issue:16 Topics: Aged; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Death, Sudden, Cardiac; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Reoperation; Sirolimus; Ticlopidine; Treatment Outcome	2007
Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial). The American journal of cardiology, 2007, Oct-01, Volume: 100, Issue:7 Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug Delivery Systems; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima	2007
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. Journal of the American College of Cardiology, 2008, Feb-12, Volume: 51, Issue:6 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20 Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Sirolimus; Ticlopidine	2008
Comparison of low vs moderate dose of atorvastatin in clopidogrel resistance after coronary stenting in Korean patients with acute coronary syndrome. Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:6 Topics: Acute Coronary Syndrome; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Clopidogrel; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Heptanoic Acids; Humans; Korea; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Single-Blind Method; Sirolimus; Ticlopidine; Time Factors	2009
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Journal of the American College of Cardiology, 2009, May-12, Volume: 53, Issue:19 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Incidence; Male; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk; Sirolimus; Ticlopidine; Tubulin Modulators	2009
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Asia; Aspirin; Cardiovascular Agents; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymers; Product Surveillance, Postmarketing; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2009
Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. The American journal of cardiology, 2009, Nov-15, Volume: 104, Issue:10 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Sirolimus; Ticlopidine	2009
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Statistics as Topic; Statistics, Nonparametric; Switzerland; Ticlopidine; Titanium	2011
Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:10 Topics: Clopidogrel; Coronary Angiography; Coronary Restenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Risk Factors; Sirolimus; Statistics as Topic; Statistics, Nonparametric; Ticlopidine; Time Factors; Ultrasonography, Interventional	2011
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation, 2012, Apr-24, Volume: 125, Issue:16 Topics: Aged; Aged, 80 and over; Aspirin; Cause of Death; Clopidogrel; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk; Sirolimus; Stroke; Thrombosis; Ticlopidine; Treatment Outcome	2012
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study. American heart journal, 2012, Volume: 164, Issue:6 Topics: Adult; Aspirin; Brazil; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Period; Prospective Studies; Research Design; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome; Young Adult	2012
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. The American journal of cardiology, 2013, Feb-15, Volume: 111, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Aspirin; Clopidogrel; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Humans; Immunosuppressive Agents; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Registries; Retrospective Studies; Sirolimus; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome; United States	2013
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY). European heart journal, 2013, Volume: 34, Issue:12 Topics: Aged; Clopidogrel; Coronary Restenosis; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Graft Occlusion, Vascular; Humans; Hyperplasia; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Sirolimus; Stents; Stroke; Ticlopidine; Tunica Intima	2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA, 2013, Dec-18, Volume: 310, Issue:23 Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Sirolimus; Stroke; Thrombosis; Ticlopidine	2013
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:1 Topics: Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Italy; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2014
Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease. American heart journal, 2014, Volume: 167, Issue:2 Topics: Aged; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome	2014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. European heart journal, 2014, Aug-01, Volume: 35, Issue:29 Topics: Aspirin; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Sirolimus; Ticlopidine; Treatment Outcome	2014
A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:1 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome; Tubulin Modulators	2014
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. American heart journal, 2014, Volume: 168, Issue:5 Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Maintenance Chemotherapy; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Failure; Risk Assessment; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2014
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. Journal of the American College of Cardiology, 2015, Mar-03, Volume: 65, Issue:8 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Early Termination of Clinical Trials; Europe; Everolimus; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Middle Aged; Middle East; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2015
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. Journal of the American College of Cardiology, 2015, Mar-03, Volume: 65, Issue:8 Topics: Aged; Aged, 80 and over; Aspirin; Biocompatible Materials; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Treatment Outcome	2015
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial. Circulation. Cardiovascular interventions, 2016, Volume: 9, Issue:2 Topics: Absorbable Implants; Aged; Antibiotics, Antineoplastic; Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Ticlopidine	2016
Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Clinical research in cardiology : official journal of the German Cardiac Society, 2017, Volume: 106, Issue:3 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Republic of Korea; Risk Factors; Sirolimus; Ticlopidine; Time Factors	2017
Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy American heart journal, 2016, Volume: 182 Topics: Acute Coronary Syndrome; Adult; Aspirin; Clopidogrel; Drug Monitoring; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Republic of Korea; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2016
Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients. The Journal of invasive cardiology, 2017, Volume: 29, Issue:3 Topics: Aspirin; Cilostazol; Clopidogrel; Comorbidity; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Treatment Outcome	2017
Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT Substudy. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2018, 03-20, Volume: 13, Issue:16 Topics: Aged; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Republic of Korea; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2018
Predictors of strut coverage of drug eluting stent implantation in diabetic patients. International journal of cardiology, 2019, Feb-01, Volume: 276 Topics: Aged; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prosthesis Design; Sirolimus; Tomography, Optical Coherence; Treatment Outcome	2019
Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE Trial. Journal of the American Heart Association, 2021, 01-05, Volume: 10, Issue:1 Topics: Aged; Aspirin; Biodegradable Plastics; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Humans; Immunosuppressive Agents; Male; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Sirolimus	2021

Other Studies

79 other study(ies) available for clopidogrel and sirolimus

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation, 2001, Aug-21, Volume: 104, Issue:8 Topics: Angioplasty, Balloon, Coronary; Animals; Calcineurin Inhibitors; Carrier Proteins; Cell Cycle Proteins; Cell Division; Cell Movement; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Graft Occlusion, Vascular; Humans; Hyperplasia; Macromolecular Substances; Phosphotransferases (Alcohol Group Acceptor); Platelet Aggregation Inhibitors; Signal Transduction; Sirolimus; Stents; Tacrolimus; Tacrolimus Binding Protein 1A; Ticlopidine; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins; Tunica Media; Vascular Patency	2001
Economics of sirolimus-eluting stents: drug-eluting stents have really arrived. Circulation, 2004, Aug-03, Volume: 110, Issue:5 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Cost-Benefit Analysis; Humans; Myocardial Revascularization; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sirolimus; Stents; Ticlopidine	2004
Very late thrombosis after implantation of sirolimus eluting stent. Heart (British Cardiac Society), 2005, Volume: 91, Issue:6 Topics: Adult; Aspirin; Blood Vessel Prosthesis; Catheterization; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Implants; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Prosthesis Failure; Retreatment; Sirolimus; Stents; Ticlopidine; Time Factors	2005
Prevention of carotid artery restenosis after sirolimus-coated stent implantation in pigs. Stroke, 2006, Volume: 37, Issue:2 Topics: Alloys; Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Carotid Arteries; Clopidogrel; Coronary Angiography; Coronary Restenosis; Disease Models, Animal; Male; Polymers; Sirolimus; Stents; Swine; Ticlopidine; Time Factors; Ultrasonics	2006
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation, 2006, Feb-28, Volume: 113, Issue:8 Topics: Aged; Angiography; Case-Control Studies; Clopidogrel; Drug Delivery Systems; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Renal Insufficiency; Sirolimus; Stents; Thrombosis; Ticlopidine; Treatment Outcome	2006
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Internet; Male; Middle Aged; Myocardial Infarction; Product Surveillance, Postmarketing; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Ticlopidine; United States	2006
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation, 2006, Jun-20, Volume: 113, Issue:24 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cause of Death; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Drug Administration Schedule; Drug Implants; Female; Follow-Up Studies; Hospitalization; Humans; Life Tables; Male; Middle Aged; Mortality; Myocardial Infarction; Patient Education as Topic; Platelet Aggregation Inhibitors; Prevalence; Proportional Hazards Models; Prospective Studies; Pyridines; Registries; Sirolimus; Stents; Survival Analysis; Thrombosis; Ticlopidine; Treatment Outcome; Treatment Refusal	2006
Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Dec-01, Volume: 63, Issue:23 Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Humans; Paclitaxel; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Stents; Ticlopidine	2006
Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. International heart journal, 2006, Volume: 47, Issue:5 Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Humans; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2006
A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent. Cardiology, 2007, Volume: 108, Issue:4 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Sirolimus; Ticlopidine; Time Factors	2007
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA, 2007, Jan-10, Volume: 297, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2007
Drug eluting stents. BMJ (Clinical research ed.), 2006, Dec-16, Volume: 333, Issue:7581 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Drug Implants; Humans; Platelet Aggregation Inhibitors; Prosthesis Failure; Referral and Consultation; Sirolimus; Stents; Thrombosis; Ticlopidine	2006
Does clopidogrel each day keep stent thrombosis away? JAMA, 2007, Jan-10, Volume: 297, Issue:2 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Thrombosis; Ticlopidine	2007
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation, 2007, May-08, Volume: 115, Issue:18 Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Drug Implants; Drug Utilization; Endothelium, Vascular; Equipment Design; Equipment Failure; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Tunica Intima; Wound Healing	2007
Clopidogrel and long-term outcomes after drug-eluting stent implantation. JAMA, 2007, Apr-25, Volume: 297, Issue:16 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2007
Clopidogrel and long-term outcomes after drug-eluting stent implantation. JAMA, 2007, Apr-25, Volume: 297, Issue:16 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2007
Clopidogrel and long-term outcomes after drug-eluting stent implantation. JAMA, 2007, Apr-25, Volume: 297, Issue:16 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Cost-Benefit Analysis; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2007
Clopidogrel and long-term outcomes after drug-eluting stent implantation. JAMA, 2007, Apr-25, Volume: 297, Issue:16 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Risk Assessment; Sirolimus; Stents; Ticlopidine	2007
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA, 2007, May-09, Volume: 297, Issue:18 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Consumer Product Safety; Female; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome; United States	2007
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre]. Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Stents; Surface Properties; Ticlopidine; Treatment Outcome	2007
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation, 2007, Jun-26, Volume: 115, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2007
Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:7 Topics: Abciximab; Aged; Angioplasty, Balloon; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Coronary Thrombosis; Heparin; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2007
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. Journal of the American College of Cardiology, 2007, Jun-19, Volume: 49, Issue:24 Topics: Adult; Antineoplastic Agents, Phytogenic; Blood Platelets; Clopidogrel; Comorbidity; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Myocardial Ischemia; Paclitaxel; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Sirolimus; Stents; Thrombosis; Ticlopidine	2007
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jul-01, Volume: 70, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Feasibility Studies; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Secondary Prevention; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2007
Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Jul-01, Volume: 64, Issue:13 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Time Factors	2007
Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation, 2007, Aug-14, Volume: 116, Issue:7 Topics: Algorithms; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Incidence; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus; Stents; Survivors; Thrombosis; Ticlopidine	2007
Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation. The Journal of invasive cardiology, 2007, Volume: 19, Issue:9 Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Time Factors	2007
Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years? Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:4 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Radiography; Reoperation; Sirolimus; Ticlopidine; Time Factors	2008
Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation. Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:4 Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Factor V; Humans; Male; Middle Aged; Mutation; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Warfarin	2008
Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation. The Journal of invasive cardiology, 2008, Volume: 20, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Feasibility Studies; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Sirolimus; Ticlopidine	2008
Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent. Thrombosis research, 2009, Volume: 124, Issue:1 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2009
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery. International journal of cardiology, 2010, Apr-01, Volume: 140, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Ventricular Fibrillation	2010
Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis. The American journal of cardiology, 2009, Feb-01, Volume: 103, Issue:3 Topics: Aged; Clopidogrel; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Ticlopidine	2009
Prolonged dual antiplatelet therapy improves clinical outcomes in high-risk patients implanted with sirolimus-eluting stents. Clinical cardiology, 2009, Volume: 32, Issue:3 Topics: Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Sirolimus; Ticlopidine; Treatment Outcome	2009
Incidence of stent thrombosis in patients with drug eluting stents and short-term dual antiplatelet therapy. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Artery Disease; Databases as Topic; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2009
Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. The American journal of cardiology, 2009, May-15, Volume: 103, Issue:10 Topics: Aged; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Disease; Drug Interactions; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Sirolimus; Ticlopidine; Treatment Outcome	2009
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Durapatite; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prosthesis Design; Registries; Sirolimus; Stainless Steel; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2008
Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Cardiovascular Agents; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Durapatite; Hyperplasia; Lipids; Materials Testing; Models, Animal; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Stainless Steel; Surface Properties; Sus scrofa; Ticlopidine; Wound Healing	2009
The excel stent: a good DES, but can we really stop clopidogrel after 6 months? JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Polymers; Prosthesis Design; Risk Assessment; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2009
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:5 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Durapatite; Female; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymers; Prospective Studies; Sirolimus; Ticlopidine; Time Factors; Ultrasonography	2009
Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Japan; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Tomography, Optical Coherence; Ultrasonography, Interventional	2009
Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation. Journal of the American College of Cardiology, 2009, Jun-16, Volume: 53, Issue:24 Topics: Aspirin; Cellular Senescence; Cilostazol; Clopidogrel; Down-Regulation; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Humans; Immunosuppressive Agents; Nitric Oxide Synthase Type III; Oxidative Stress; Paclitaxel; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Sirolimus; Sirtuin 1; Sirtuins; Tetrazoles; Ticlopidine; Vasodilator Agents	2009
The carina angle-new geometrical parameter associated with periprocedural side branch compromise and the long-term results in coronary bifurcation lesions with main vessel stenting only. Journal of interventional cardiology, 2009, Volume: 22, Issue:6 Topics: Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Image Interpretation, Computer-Assisted; Immunosuppressive Agents; Male; Mathematics; Multivariate Analysis; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Poland; Registries; Retrospective Studies; Sirolimus; Statistics as Topic; Ticlopidine; Time Factors	2009
Triple antiplatelet therapy for clopidogrel resistance with stent malapposition: a case report. Chinese medical journal, 2009, Sep-20, Volume: 122, Issue:18 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2009
Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years. Journal of the American College of Cardiology, 2010, Feb-16, Volume: 55, Issue:7 Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Creatinine; Diabetes Mellitus; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Stroke Volume; Ticlopidine	2010
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy. Journal of cardiovascular medicine (Hagerstown, Md.), 2011, Volume: 12, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Ticlopidine; Time Factors	2011
Combination of clopidogrel and everolimus dramatically reduced the development of transplant arteriosclerosis in murine aortic allografts. Transplant international : official journal of the European Society for Organ Transplantation, 2010, Volume: 23, Issue:9 Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Everolimus; Graft Rejection; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Platelet Aggregation; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Transplantation, Homologous; Treatment Outcome	2010
Late and very late stent thrombosis after polymer-based sirolimus- or paclitaxel-eluting stent implantation in real-world clinical practice. Chinese medical journal, 2010, Apr-05, Volume: 123, Issue:7 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Sirolimus; Ticlopidine	2010
Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2010
Impact of cytochrome P450 2C192 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:1* Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Cardiovascular Agents; Chi-Square Distribution; Cineangiography; Clopidogrel; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Japan; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2011
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Arte JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:12 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Clopidogrel; Confidence Intervals; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Risk Reduction Behavior; Sirolimus; Ticlopidine; Time Factors	2010
A case of subacute thrombosis associated with clopidogrel resistance after implantation of a zotarolimus-eluting stent. Heart and vessels, 2012, Volume: 27, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Anterior Wall Myocardial Infarction; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug Resistance; Drug-Eluting Stents; Female; Genotype; Humans; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prosthesis Design; Sirolimus; Thrombectomy; Thrombosis; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional	2012
Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy. The American journal of cardiology, 2011, Sep-01, Volume: 108, Issue:5 Topics: Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Sirolimus; Stents; Ticlopidine; Transplantation, Homologous; Treatment Outcome; Tubulin Modulators	2011
Influence of low-dose aspirin (81 mg) on the incidence of definite stent thrombosis in patients receiving bare-metal and drug-eluting stents. Clinical cardiology, 2011, Volume: 34, Issue:9 Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Sirolimus; Statistics as Topic; Ticlopidine	2011
Stent-related cardiac events beyond three years after implantation of the sirolimus-eluting stent (from the EVASTENT Patients). The American journal of cardiology, 2011, Nov-15, Volume: 108, Issue:10 Topics: Clopidogrel; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Matched-Pair Analysis; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Registries; Sirolimus; Ticlopidine	2011
Three-year clinical outcome with the Endeavor™ zotarolimus-eluting stent in primary percutaneous coronary intervention for ST elevation myocardial infarction: the Endeavor™ primary PCI study (E-PPCI). Journal of interventional cardiology, 2011, Volume: 24, Issue:6 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Confidence Intervals; Drug-Eluting Stents; Female; Heparin; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome; United Kingdom	2011
Medium to long-term clinical outcomes with everolimus-eluting stents in real-life percutaneous coronary intervention. Annals of the Academy of Medicine, Singapore, 2012, Volume: 41, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; New Zealand; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Sirolimus; Survival Analysis; Ticlopidine; Time Factors; Treatment Outcome	2012
When coronary angiography is not enough to detect spontaneous left main coronary artery dissection. Minerva cardioangiologica, 2012, Volume: 60, Issue:4 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aortic Dissection; Aspirin; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Metoprolol; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Smoking; Ticlopidine; Treatment Outcome	2012
Clinical efficacy and safety of biodegradable polymer-based sirolimus-eluting stents in patients with diabetes mellitus insight from the 4-year results of the create study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Jun-01, Volume: 81, Issue:7 Topics: Absorbable Implants; Aged; Aspirin; Cardiovascular Agents; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2013
Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins? Journal of the American College of Cardiology, 2012, Oct-09, Volume: 60, Issue:15 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Medication Adherence; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Sirolimus; Ticlopidine; Withholding Treatment	2012
A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Nov-22, Volume: 8, Issue:7 Topics: Absorbable Implants; Aged; Aspirin; Cardiovascular Agents; China; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2012
Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents. Coronary artery disease, 2013, Volume: 24, Issue:3 Topics: Aged; Aspirin; Cardiovascular Agents; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2013
Quantitative assessment of late lumen loss after biodegradable polymer and permanent polymer sirolimus-eluting stents implantation. Chinese medical journal, 2013, Volume: 126, Issue:6 Topics: Aged; Aspirin; Clopidogrel; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Polymers; Regression Analysis; Sirolimus; Ticlopidine	2013
Clopidogrel reduces post-transplant obliterative bronchiolitis. Transplant international : official journal of the European Society for Organ Transplantation, 2013, Volume: 26, Issue:10 Topics: Animals; Blood Platelets; Bronchiolitis Obliterans; Calcineurin Inhibitors; Clopidogrel; Cytokines; Everolimus; Gene Expression Regulation; Immunohistochemistry; Isoantibodies; Lung Diseases; Lung Transplantation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Microscopy, Fluorescence; Models, Animal; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; T-Lymphocytes; Tacrolimus; Ticlopidine; Time Factors; TOR Serine-Threonine Kinases; Trachea	2013
Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents. The American journal of cardiology, 2013, Dec-15, Volume: 112, Issue:12 Topics: Aged; Aged, 80 and over; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Sirolimus; Thiophenes; Ticlopidine; Treatment Outcome	2013
Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2015, Volume: 47, Issue:1 Topics: Allografts; Animals; Aorta; Arteriosclerosis; Clopidogrel; Disease Progression; Everolimus; Immunity, Humoral; Isoantibodies; Mice; Mice, Inbred C57BL; Sirolimus; Ticlopidine	2015
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents. The American journal of cardiology, 2014, Jun-15, Volume: 113, Issue:12 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Retrospective Studies; Severity of Illness Index; Sirolimus; Survival Analysis; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment	2014
Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation. International journal of cardiology, 2015, Jan-20, Volume: 179 Topics: Aged; Clopidogrel; Coronary Angiography; Cytochrome P-450 Enzyme System; Drug-Eluting Stents; Everolimus; Female; Genotype; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Tomography, Optical Coherence	2015
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients with acute myocardial infarction. International journal of cardiology, 2015, Mar-15, Volume: 183 Topics: Absorbable Implants; Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Ticlopidine; Treatment Outcome	2015
Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy. JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3 Topics: Aged; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2015
Stent selection and antiplatelet therapy duration: one size does not fit all. Journal of the American College of Cardiology, 2015, Mar-03, Volume: 65, Issue:8 Topics: Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Postoperative Complications; Sirolimus; Ticlopidine	2015
Clinical impact of dual antiplatelet therapy use in patients following everolimus-eluting stent implantation: insights from the SEEDS study. Chinese medical journal, 2015, Mar-20, Volume: 128, Issue:6 Topics: Adolescent; Adult; Aged; Aspirin; Clopidogrel; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome; Young Adult	2015
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - . Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:6 Topics: Adventitia; Aged; Aged, 80 and over; Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Everolimus; Female; Humans; Interferometry; Male; Middle Aged; Neointima; Neovascularization, Physiologic; Platelet Aggregation Inhibitors; Postoperative Period; Prosthesis Implantation; Sirolimus; Stents; Swine; Swine, Miniature; Ticlopidine; Tomography, Optical Coherence; Vasa Vasorum; Vasculitis	2015
Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes after endeavor sprint zotarolimus-eluting stent implantation in patients presenting with acute coronary syndrome. European journal of internal medicine, 2015, Volume: 26, Issue:7 Topics: Acute Coronary Syndrome; Aged; Cause of Death; Clopidogrel; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Republic of Korea; Sirolimus; Ticlopidine; Treatment Outcome	2015
Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation. Heart and vessels, 2016, Volume: 31, Issue:8 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Thrombosis; Ticlopidine; Tomography, Optical Coherence	2016
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent. Medicine, 2015, Volume: 94, Issue:46 Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Registries; Sirolimus; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome	2015
Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs. Anatolian journal of cardiology, 2017, Volume: 18, Issue:6 Topics: Clopidogrel; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Preoperative Period; Retrospective Studies; Sirolimus; Thrombosis	2017
Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy. Journal of cardiology, 2018, Volume: 72, Issue:1 Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Japan; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Tomography, Optical Coherence	2018